Stay updated with breaking news from Alimera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a report issued on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. ALIM has been the subject of several other research reports. Alliance Global Partners raised shares of Alimera Sciences from a neutral rating to a buy rating […]
Dublin, June 29, 2023 (GLOBE NEWSWIRE) -- The "Diabetic Retinopathy Market Size, Share & Trends Analysis Report By Type (Proliferative DR,...
Analysts at StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research note issued on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on ALIM. Alliance Global Partners raised shares of Alimera Sciences from a “neutral” rating […]
Karyopharm Therapeutics (NASDAQ:KPTI – Get Rating) and Alimera Sciences (NASDAQ:ALIM – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability. Valuation and Earnings This table compares Karyopharm Therapeutics and […]
Analysts’ new coverage for Sunday, June 25th: StockNews.com initiated coverage on shares of ATA Creativity Global (NASDAQ:AACG). The firm issued a sell rating on the stock. StockNews.com started coverage on shares of Atlantic American (NASDAQ:AAME). StockNews.com issued a hold rating on the stock. StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS). StockNews.com issued a […]